Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the potential impact a mandated nondisclosure agreement could have on US Food and Drug Administration activities and its employees (:34), as well as the changes the agency’s hiring push caused to user fee reauthorization efforts (13:50). More On These Topics From The Pink Sheet Proposed Government Nondisclosure Agreement Could Include US FDA Pre-Decisional Memos: https://insights.citeline.com/pink-sheet/product-reviews/proposed-government-nondisclosure-agreement-could-include-us-fda-pre-decisional-memos-BTEWGHSQBZGVDCXOCH77CDU7LU/ US FDA Hiring Push Threatens Industry Efforts To Contain, Lower User Fees: https://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/us-fda-hiring-push-threatens-industry-efforts-to-contain-lower-user-fees-X5GTZH4JEVD3NPREWLMWKCVB6Q/